Use access key #2 to skip to page content.
$50.84 2.00 (4.10%)
7/3/2008 1:00 PM

Amgen, Inc. (AMGN)

CAPS Rating:
****

A biotechnology company whcih discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.

View All Commentary (AMGN)

Recs

0

Avatar JustWokeUp (72.97) Submitted: 5/06/08 9:30 PM : Underperform Start Price: $42.97 AMGN Score: -5.66

AMGN was a great company with a great list of drugs and developments.

However the momentum is now gone (it has gone for a couple of months) and what's left is speculations that other drugs in the pipeline will become the next blockbuster. As the regulations tighten and more and more restrictions are made (e.g. on Aranesp use), AMGN is not going to move up for the next couple of months, at least. Wait for the stock to pass $45 to make a buy.

Unless some sudden great news emerge.

Report this Post Replies: 0 | Reply

Featured Broker Partners